As of Oct 20
| +0.14 / +5.34%|
The 4 analysts offering 12-month price forecasts for Catalyst Pharmaceuticals Inc have a median target of 5.50, with a high estimate of 6.00 and a low estimate of 4.75. The median estimate represents a +99.28% increase from the last price of 2.76.
The current consensus among 4 polled investment analysts is to Buy stock in Catalyst Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.